CD8+CD28−suppressor T lymphocytes are almost persistent and functional in human tumors and are able to inhibit both proliferation and cytotoxicity of T cells, with pathogenic relevance and significance for immunotherapy of cancer [32]. This evidence concerns the gene CD8A and cancer.